NCT02221232

Efficacy Study to Evaluate Antimicrobial Effectiveness of ZuraPrep™

A Pilot Clinical Evaluation of the Antimicrobial Effectiveness of Topically Applied ZuraPrep™

• Status: Terminated
• Phase: Phase 2
• Study type: Interventional
• Enrollment: 64 (actual)
• Sponsor: Zurex Pharma, Inc. · Industry
• Sex: All
• Age: 18 Years
• Healthy volunteers: Accepted

Summary

The purpose of this pilot study is to evaluate antimicrobial properties of a single test product, a vehicle product and a reference product applied in two different areas when used as a patient preoperative skin preparation.

Detailed description

This is an open label pilot study to evaluate antimicrobial properties of a single test product, a vehicle product and a reference product applied bilaterally to the skin of the abdomen and the inguina. Testing will be performed according to FDA TFM for Effectiveness Testing of a Patient Preoperative Skin Preparation.

Conditions

• Surgical Site Infection

Interventions

Type	Name	Description
DRUG	Chloraprep	Apply topically.
DRUG	ZuraPrep	Apply topically.
DRUG	ZuraPrep Vehicle	Apply topically.

Timeline

• Start date: 2014-08-01
• Primary completion: 2014-10-01
• Completion: 2014-10-01
• First posted: 2014-08-20
• Last updated: 2016-07-18

Locations

1 site across 1 country: United States